Mondego Bio: A New Frontier in Immuno-Oncology Funding Success Mondego Bio has emerged from Expert Systems Inc. with Series A funding aimed at combating immune resistance in solid tumors, revolutionizing cancer treatments.

Mondego Bio: A New Frontier in Immuno-Oncology Funding Success #Portugal #Expert_Systems #Mondego_Bio #PTPN2_inhibitors #Cantanhede

Biovance Capital Secures Series A Funding for Mondego Bio's Innovative Cancer Treatments Biovance Capital has led a significant Series A funding round for Mondego Bio, a startup focused on pioneering cancer therapies. Their work on PTPN2 inhibitors shows promise for improving immunotherapy outcomes.

Biovance Capital Secures Series A Funding for Mondego Bio's Innovative Cancer Treatments #Portugal #Lisbon #Biovance_Capital #Mondego_Bio #PTPN2_inhibitors